TAB008 Compared to Avastin® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer

NCT05427305 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

549

Enrollment

INDUSTRY

Sponsor class

Conditions

Efficacy

Interventions

DRUG: TAB008
DRUG: Bevacizumab

Sponsor

BioDlink Biopharm Co., Ltd.